Concepedia
2
Publications
99
Citations
H-Index
2021
Active since
Affiliations
AstraZeneca (Sweden)(Current)
AstraZeneca (United States)
Yvo J.M. Op den Kamp is an author at AstraZeneca (Sweden).
Publications per year
2021–2022
Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial
Yvo J.M. Op den Kamp, Marlies de Ligt, Bas Dautzenberg et al. · Diabetes Care · 2021 · 57 citations · Full text
Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism
Yvo J.M. Op den Kamp, Anne Gemmink, Marlies de Ligt et al. · Molecular Metabolism · 2022 · 42 citations · Full text
Rows per page
1–2 of 2